Monthly Archives: March 2011

Clinical Trials: Three Dimensions of Success


Dr Michael Silverman, principal at BioStrategics Consulting Ltd., talks about the necessity to view the success of a clinical trial from three very different perspectives, each of which has its own unique business implications, audience and role in resource allocation … Continue reading

Posted in Clinical, Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Clinical Trials in the USA for Ex-USA Companies


Dr Michael Silverman of BioStrategics Consulting Ltd discusses his role in helping several ex-USA companies conduct their clinical trial development programs in the USA under USA regulations and in USA facilities. Over the last 20 years of consulting for, and … Continue reading

Posted in Clinical studies, Services | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

5 Commercial Considerations of Clinical Trial End Points and Measures


Dr Michael Silverman of BioStrategics Consulting Ltd discusses five commercial considerations of clinical trial end points and their implications for the company and the drug. The selection of an end point for a clinical trial can be a decision with … Continue reading

Posted in Clinical studies, clinical trials | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Placebo-Controlled Clinical Trials. Are They Still Relevant?


Dr Michael Silverman of BioStrategics Consulting Ltd raises the question and discusses the relevance of placebo-controlled clinical studies in medicine and drug development today. Of course a placebo-controlled study is far superior in addressing the question of does your drug … Continue reading

Posted in Clinical, Clinical studies, clinical trials, Medical | Tagged , , , , , , , , , , , , , , , , , | Leave a comment